By Cynthia Chmielewski | Posted - Nov 27th, 2021





HealthTree University: Specific Myeloma Genetics Mutations and Risk (3/3)

Did you know that the genetics of your myeloma affect how high-risk or low-risk your disease is? Some of the top myeloma doctors in the world answered our questions about risk, genetics and even treatment of the different cytogenetic abnormalities that crop up in multiple myeloma. You can watch the following HealthTree University videos to learn more about this important aspect of your disease. You can watch the entire course at

20.11    Will Del17p and other chromosomal abnormalities go away after an auto ASCT? If not why may it not be detected?


20.12    What are genetic sub groups in myeloma base? What testing is done to identify sub-group?


20.13    (Guest Lecture): Risk Classification | Myeloma Crowd Round Table on Genetics


20.14    (Guest Lecture): Myeloma Sub-Population Genetic Characteristics | Myeloma Crowd Round Table on Genetics


20.15    (Guest Lecture): Audience Questions & Answers | Myeloma Crowd Round Table on Genetics


We’d like to thank our faculty who donated their time in creating these videos, including:

  • Cesar Rodriguez Valdes, MD
  • Leif Bergsagel, MD
  • Fotis Asimakopoulos, MD, PhD
  • Faith Davies, MBBCh, MCRP, MD FRCPath
  • Sikander Ailawadhi, MD
  • Brian Van Ness, PhD

Want more?

We have over 300 HealthTree University videos online at! Learn the basics (and the not-so-basics) of myeloma from some of the top myeloma doctors in the world!


Cynthia Chmielewski
About the Author

Cynthia Chmielewski - Cynthia Chmielewski is a professional educator and myeloma advocate. As a former teacher, she now teaches myeloma patients how to advocate for themselves as the Director of HealthTree University.


Add a Comment



Thanks to our Myeloma Crowd Community sponsors:

.                         .       .